initial public offerings (IPOs) trading on American exchanges

Wednesday, September 15, 2021

PROCEPT BioRobotics (PRCT) began trading on the Nasdaq on Wed 15 Sep 21

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). 

Procept, Inc. priced upsized 6.556 mln share IPO at $25.00 per share, above the $22-24 expected range

No comments:

Post a Comment